|
February 6, 2018 1:20 FDA clears first smart watch for use in epilepsy https://www.cnbc.com/2018/02/05/pr-newswire-embrace-by-empatica-is-the-worlds-first-smart-watch-to-be-cleared-by-fda-for-use-in-neurology.html 3:39 FDA Clears IND application for TRE-515, a first-in-class inhibitor of deoxycytidine kinase for myelodysplastic syndrome http://trethera.com/fda-clearance-investigational-new-drug-application-tre-515/ 6:13 FDA Clears IND application for ORC-13661, which could be the first medicine approved specifically to prevent hearing loss of patients using certain antibiotics https://www.prnewswire.com/news-releases/fda-clears-oricula-therapeutics-investigational-new-drug-application-for-clinical-trials-300592718.html 7: 51 Nascent Medical info@nascentmc.com Visit this podcast's website at http://www.newfdaappovals.com |